Predict your next investment

Corporation
amo-inc.com

See what CB Insights has to offer

About Abbot Medical Optics

Abbot Medical Optics is a corporation based out of Santa Ana, California.

Abbot Medical Optics Headquarter Location

1700 East St. Andrew Place

Santa Ana, California, 92705,

United States

(714)247-8200

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Abbot Medical Optics News

indie Semiconductor Announces Retirement of Bill Woodward and Appointment of Diane Biagianti to Its Board of Directors

Mar 29, 2022

03/29/2022 | 05:43pm EDT Message : *Required fields Original indie Investor and Partner Steps Down post IPO while Adding Legal Executive who Brings Broad Corporate Governance Experience indie Semiconductor (Nasdaq: INDI), an Autotech solutions innovator, today announced that Bill Woodward has retired and Diane Biagianti has been appointed to its board of directors. Biagianti currently serves as senior vice president and general counsel for Glaukos Corporation, a publicly traded medical technology and pharmaceutical company. Prior to joining Glaukos in 2020, Biagianti was chief responsibility officer for nine years at Edwards Lifesciences, a global leader in patient-focused medical innovations for structural heart disease and critical care and surgical monitoring, responsible for global ethics and compliance, corporate sustainability and information security. Previously, she was with Advanced Medical Optics from 2002 to 2009, serving in various leadership positions, including as senior vice president and general counsel, and division vice president, legal section head upon Abbott Laboratories’ acquisition of Advanced Medical Optics in 2009 until 2011. Earlier, from 1997 to 2002, she served as vice president and assistant general counsel for Experian Information Solutions, Inc. She has also worked as a labor and employment attorney for O’Melveny & Myers LLP and a senior accountant for M.J. Seby & Associates, Ltd., CPAs. “It has been an honor to be part of indie’s early journey, delivering and leading the original funding and helping to guide a talented team of entrepreneurs - now friends - from the very start,” said Bill Woodward, founder and managing director of Anthem Ventures. “indie has an incredible journey ahead of it and I will always be a long-term believer and investor and, as always, will continue to assist indie's outstanding management team and board of directors.” “Over the past two decades, Bill has provided indie with invaluable advice and guidance and shaped indie into the successful public company we are today,” said Donald McClymont, indie’s co-founder and CEO. “Bill is a visionary and instilled tenacity, a customer-centric focus and financial discipline into our DNA from the launch of indie back in 2007. I thank him for his numerous contributions along the way, which are too long to list within a press release. Quite simply, we wouldn’t be where we are today without Bill Woodward and, while we’ll miss him incredibly at the board level, I look forward to continuing our long-standing mentorship and friendship.” “We are delighted to welcome Diane to our board of directors,” said David Aldrich, indie’s chairman of the board. “Diane is an accomplished business executive with extensive legal, corporate governance and cybersecurity expertise. Her insights will be invaluable as indie transitions to the next level via organic performance and M&A. I would also like to thank Bill for his stewardship of indie from inception to completion of our IPO. We will miss him greatly.” “I am excited to be joining indie’s board of directors at this key growth stage,” said Biagianti. “indie is providing foundational technologies and products underpinning several strategic megatrends across automotive semiconductors. I look forward to leveraging my skillsets to support indie’s vision of creating an Autotech powerhouse.” Biagianti earned a juris doctorate from Cornell University and a bachelor’s degree in business administration from the University of Arizona. She currently serves on the Audit and Governance Committees for Human Options, a non-profit organization supporting lives free from fear and domestic violence. From 2009 to 2021, she served as a board member and was Board President from 2019 to 2020 for this non-profit organization. She previously served as a member of the Orange County Bar Association Corporate Committee, and a board member of the Constitutional Rights Foundation. Biagianti is the recipient of PwC award for Leadership in the Advancement of Ethics in the medical device industry, the Orange County Anti-Defamation League Marcus Kaufman Jurisprudence award, and the Warren Christopher Values award. About indie indie is empowering the Autotech revolution with next generation automotive semiconductors and software platforms. We focus on edge sensors spanning multiple modalities including LiDAR, radar, ultrasound and vision for Advanced Driver Assistance Systems (ADAS), autonomous vehicles, connected car, user experience and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the advanced user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms we rely on every day. We are an approved vendor to Tier 1 partners and our solutions can be found in marquee automotive OEMs around the world. Headquartered in Aliso Viejo, CA, indie has design centers and sales offices in Austin, TX; Boston, MA; Detroit, MI; San Francisco and San Jose, CA; Budapest, Hungary; Dresden and Munich, Germany; Edinburgh, Scotland; Haifa, Israel; Quebec City, Canada; Tokyo, Japan and several locations throughout China. Please visit us at www.indiesemi.com to learn more. Safe Harbor Statement This communication contains “forward-looking statements” (including within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended). Such statements include, but are not limited to, statements regarding our future business and financial performance and prospects, and other statements identified by words such as “will likely result,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “plan,” “project,” “outlook,” “should,” “could,” “may” or words of similar meaning. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results included in such forward-looking statements. In addition to the factors previously disclosed in our registration statement on Form S-1 (SEC File No. 333-257629) and in our other public reports filed with the SEC (including those identified under “Risk Factors” therein), the following factors, among others, could cause actual results and the timing of events to differ materially from the anticipated results or other expectations expressed in the forward-looking statements: the impact of the COVID-19 pandemic; our reliance on contract manufacturing and outsourced supply chain and the availability of semiconductors and manufacturing capacity; competitive products and pricing pressures; our ability to win competitive bid selection processes and achieve additional design wins; the impact of any acquisitions we may make; our ability to develop, market and gain acceptance for new and enhanced products and expand into new technologies and markets; trade restrictions and trade tensions; our ability to build, staff and integrate new design, testing, sales and marketing facilities throughout the world; and political and economic instability in our target markets. indie cautions that the foregoing list of factors is not exclusive and investors are encouraged to read the additional risks and uncertainties previously disclosed in our registration statement on Form S-1 (SEC File No. 333-257629) and in our other public reports filed with the SEC (including those identified under “Risk Factors” therein). All forward-looking statements in this press release are expressly qualified in their entirety by the foregoing cautionary statements. Investors are cautioned not to place undue reliance on the forward-looking statements in this press release, which information set forth herein speaks only as of the date hereof. We do not undertake, and we expressly disclaim, any intention or obligation to update any forward-looking statements made in this announcement or in our other public filings, whether as a result of new information, future events or otherwise, except as required by law. #indieSemi_Corporate © Business Wire 2022

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.